Herbert Koenig

Title: Herbert Koenig: Innovator in Pharmaceutical Compounds

Introduction

Herbert Koenig is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that promote neuronal growth and repair. With a total of 2 patents, his work has the potential to impact the treatment of various neuropathies and myopathies.

Latest Patents

Koenig's latest patents focus on compounds having a guanidine structure. These guanidine derivatives are designed to promote the growth, repair, and regeneration of neuronal axons. They are particularly useful in treating neuropathies and myopathies. The compounds are characterized by a specific formula, wherein R1 can be an isopropyl radical or a benzyl radical, which may be substituted by one or more (C1-C6) alkoxy radicals. Additionally, R2, R3, and R4, along with the nitrogen atoms to which they are attached, form a pyrimidine ring or a pyrimidinium ring.

Career Highlights

Herbert Koenig is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His work there has allowed him to explore innovative solutions in the pharmaceutical field, particularly in the area of neuronal health.

Collaborations

Koenig has collaborated with notable colleagues, including Claude Thal and Catherine Quirosa-Guillou. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Herbert Koenig's contributions to pharmaceutical innovations highlight the importance of research in treating neurological conditions. His work continues to pave the way for new therapeutic approaches in medicine.